ThermoGenesis Holdings, Inc.

Equities

THMO

US88362L2097

Office Equipment

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.68 USD 0.00% Intraday chart for ThermoGenesis Holdings, Inc. +2.63% +13.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Traders Await -2- DJ
North American Morning Briefing : Powell Awaited -2- DJ
Thermogenesis Holdings, Inc. Announces Resignation of Haihong Zhu, Chief Operating Officer and A Director from the Board CI
ThermoGenesis Files $30 Million Mixed Shelf MT
Transcript : ThermoGenesis Holdings, Inc., Q3 2023 Earnings Call, Nov 13, 2023
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
ThermoGenesis Holdings, Inc. to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento CI
ThermoGenesis Holdings, Inc. Announces Management Changes CI
Transcript : ThermoGenesis Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
ThermoGenesis Holdings, Inc. announced that it has received $1 million in funding CI
ThermoGenesis Holdings, Inc. Announces Board Appointments CI
Top Premarket Gainers MT
North American Morning Briefing : Retail Sales, -2- DJ
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : ThermoGenesis Holdings, Inc., Q1 2023 Earnings Call, May 15, 2023
ThermoGenesis Files Shelf for Up to 3 Million Common Shares on Behalf of Selling Stockholder MT
ThermoGenesis Holdings Files Shelf on Behalf of Selling Stockholder MT
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : ThermoGenesis Holdings, Inc., Q4 2022 Earnings Call, Mar 30, 2023
ThermoGenesis Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
ThermoGenesis Holdings, Inc. acquired CDMO facility. CI
ThermoGenesis Holdings Closes $3 Million Private Placement MT
ThermoGenesis Holdings, Inc. announced that it has received $2.999907 million in funding CI
Chart ThermoGenesis Holdings, Inc.
More charts
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.68 USD
Average target price
5 USD
Spread / Average Target
+635.29%
Consensus